Contineum Therapeutics, Inc. (CTNM)
NASDAQ · Healthcare
Contineum Therapeutics, Inc. Cash on Hand 2023–2024
Contineum Therapeutics, Inc. annual/quarterly cash on hand history from 2023 to 2024. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Contineum Therapeutics, Inc. cash on hand for the quarter ending December 31, 2024 were 21.9M, a 41.33% increase year-over-year.
- Contineum Therapeutics, Inc. cash on hand for 2024 were 21.9M, a 41.33% increase from 2023.
- Contineum Therapeutics, Inc. cash on hand for 2023 were 15.5M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Contineum Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2024 | $22 |
| 2023 | $16 |
| Contineum Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2024-12-31 | $22 |
| 2023-12-31 | $16 |
Contineum Therapeutics, Inc. Cash on Hand — FAQ
Contineum Therapeutics, Inc. (CTNM) cash on hand over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTNM's cash on hand history?
The chart and table above show Contineum Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.